This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Anna French
Principal at Qiming Venture Partners USA


Anna French, Ph.D. is a Principal at Qiming Venture Partners USA. Dr. French serves on the board of WindMIL Therapeutics and is a board observer with Talaris Therapeutics, Cadent Therapeutics, Let’sGetChecked and Platelet Biogenesis.

Prior to joining Qiming, Dr. French was a management consultant at the Boston Consulting Group (BCG) where she advised leading biopharma companies on their strategy and operations. She also led a global industry-academic consortium focused on cell therapy commercialization. Dr. French earned a D.Phil from the University of Oxford, UK. She has over 20 publications in the field of stem cell research.

Agenda Sessions

  • Panel: Investment view on Innovation in Cell & Gene Therapy